NEW YORK — Shiseido is preparing to unleash Benefiance Wrinkle Lifting Concentrate, its latest product derived through a research venture involving the cosmetics company, Harvard Medical School and Massachusetts General Hospital. To launch in November, the antiage item could generate first-year U.S. retail sales of $3.5 million. For more, see story, "Shiseido Hopes for Benefiance Boon."

To access this article, click here to subscribe or to log in.

load comments
blog comments powered by Disqus